Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranpirnase topical for genital warts
NCT02535104Phase 2Completed
- Sponsor
- Tamir Biotechnology, Inc.
- Start
- Feb 2016
- Primary completion
- Sep 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ranpirnase in condylomata acuminata, sponsored by Tamir Biotechnology, Inc.. Started Feb 2016; status: completed.
02
Drugs
ranpirnase
03
Conditions
condylomata acuminata
Beyond the preview
Go deeper on NCT02535104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02535104.